Compounds displaying more than 50% cytotoxicity at 10 μM were selected for further testing in a panel of five cancer cell lines: MDA-MB-435, MCF-7, PC3, HCT116 p53+/+ and HCT 116 p53-/-. This evidence concerns the gene TP53 and cancer.